Table 2 Logistic regression analysis for the primary outcome. Dependent variable: improvement of ADL

Edaravone use

1.21

1.07–1.36

0.002

1.18

1.01–1.37

0.032

Age, per 10 years

0.68

0.63–0.73

 < 0.001

0.72

0.65–0.79

< 0.001

Male

1.33

1.18–1.49

 < 0.001

1.18

1.02–1.36

0.025

BMI < 20 kg/m²

0.80

0.69–0.92

0.002

0.93

0.79–1.11

0.439

JCS at admission

0

reference

reference

1–3

0.99

0.88–1.11

0.847

1.04

0.89–1.20

0.623

10–30

0.55

0.44–0.69

 < 0.001

0.63

0.48–0.83

0.001

100–300

0.32

0.20–0.51

 < 0.001

0.38

0.21–0.67

0.001

eGFR < 60 mL/min /1.73m²

0.92

0.81–1.06

0.243

1.08

0.93–1.25

0.304

HTN medication at onset

0.86

0.76–0.98

0.019

0.86

0.74–1.01

0.058

Intravenous drug use^a

1.08

0.92–1.28

0.338

0.94

0.77–1.15

0.527